INS and Obesity: The aberrant activation of signaling cascades mediated by insulin and the insulin-like growth factor (IGF) family has been implicated in the pathophysiology of numerous ailments, including diabetes, cancer, obesity, neurodegenerative disorders, and musculoskeletal conditions (30–33).